The Operating Theatre Journal July 2022

More documents

Recommendations

Info

BPR Medical and Medclair seal mobile nitrous oxideconversion system agreementGas control specialists BPR Medical and Medclair, a leading Swedenbasedspecialist in safe nitrous oxide use, have signed an agreementthat gives BPR exclusive rights to supply Medclair’s mobile nitrous oxideconversion technology in the UK and Ireland.Under the agreement, BPR will distribute and provide support forMedclair’s MDU device, which when combined with BPR’s Ultraflowdemand valve and a gas scavenging system, captures nitrous oxide andconverts 99% of the gas to harmless nitrogen and oxygen.Head of Sales & Marketing at BPR Medical, Safoura Sardari added,“Early adopters are already embracing this technology, including Trustsin Scotland, the Northeast, London, Wales and the Southwest. We arenow expanding our business development team to meet the increasingdemand from the NHS and private healthcare settings across the UK.”The Delivering a ‘Net Zero’ National Health Service report, publishedin 2020, sets out a goal of reducing greenhouse gas emissions by 80 percent with the next six to ten years and achieving ‘net zero’ by 2040.Sources: Delivering a ‘Net Zero’ National Health Service, 2020Nitrous oxide is used by 80 per cent of women in labour in the UK.It is also used widely in other hospital departments, from endoscopyto dentistry. The gas is one of the most environmentally harmfulanaesthetic gases, with a global warming potential 298 times that ofcarbon dioxide (CO2).For further information please contact:Colin Hallmark, BPR Medical, Tel: +44 207 736 1888,email: colin@3nine.co.uk www.bprmedical.comJeta Smids, Communications Manager, Medclair AB,Tel: +46 79 101 14 64, e-mail jeta.smids@medclair.comwww.medclair.comWhen responding to articles please quote ‘OTJ’Jonas Lundh, CEO of Medclair, said: “Capturing and converting nitrousoxide emissions could reduce NHS anaesthetic gas emissions by a thirdif the technology was implemented across all Hospital Trusts in the UK.The agreement with BPR, which has a strong presence and reputation inthe market with its inhaled analgesia products, is a major step forwardin our goal of supporting the NHS with its environmental targets.”Richard Radford, Managing Director of BPR Medical, said: “The NHS hasone of the most developed nitrous oxide programmes in the world. Itdelivers safe, efficient pain relief to hundreds of patients every day. Butthe gas has a significant impact on the environment and can also affectworking conditions for staff.“There is now a solution though, which has been successfully deployedin Scandinavia for almost two decades and is already being used inhospitals across the UK. Our agreement with Medclair means we cancontinue to help more Trusts play their part in achieving ‘net zero’goals and meet audit standards.“As innovators of safer medical gas therapy, we are bringing togetherour Ultraflow analgesia system and Medclair’s MDU technology to extendour commitment to improving patient care and the work environmentfor healthcare professionals.”Are You Linkedin ?Join our GroupThe Operating Theatre Journalin TMHealthcare Safety Investigations Conference 202221 September 202210am-4pmWe would like to invite you to our Healthcare Safety InvestigationsConference this September.This is a virtual event that will take place online.Our exciting agenda includes:• a focus on our maternity, national and investigation educationprogrammes• sharing our learning so you can help make patient care safer in yourorganisation• updates and expertise on conducting professional healthcare safetyinvestigations in your setting• the future of our national and maternity programmes, as they form intoeither the Health Services Safety Investigations Body (HSSIB) or thenew maternity Special Health Authority.More information will be sent to you shortly, but please register and reserveyour place now.By registering, you'll receive updates about the conference in the run-up tothe event, including opportunities to sign-up for breakout sessions which willbe made available to you by mid-July.Register for your free place at: https://bit.ly/HSIBOTJ62214 THE OPERATING THEATRE JOURNAL www.otjonline.com
New report reveals underestimated risks for theatre staff andpatients exposed to surgical plumePerioperative practitioners in the UK are universally concerned aboutthe risk surgical smoke plume poses to their health. Yet less than afifth are aware of any policy being in place to manage this risk withintheir organisation. The majority of hospitals have plume evacuationequipment in place, but it is only used in the minority of surgicalprocedures. Almost three-quarters of theatre staff have experiencedsymptoms associated with exposure to surgical smoke plume. Butthese symptoms are rarely reported and, when they are, no action isgenerally taken.These are the findings of a new report ‘The Occupational Hazardsof Surgical Smoke Plume in the Operating Theatre’ published by theSurgical Plume Alliance (SPA), a joint advocacy initiative between theAssociation for Perioperative Practice (AfPP) and the InternationalCouncil on Surgical Plume (ICSP). They aimed to gain a greaterunderstanding of the awareness levels, training, management andpolicy surrounding surgical smoke plume in the UK.The report analyses responses from 955 perioperative practitioners– including Registered Nurses, Operating Department Practitioners(ODPs) and surgeons – surveyed in late 2021.Some key findings from the report include:• Demand for a recognised, national training programme. 52% ofperioperative practitioners have not received any education on thehazards of exposure to surgical smoke plume. However, 96% wouldattend training if it were made available.• National guidance is needed to mandate the use of evacuationequipment during surgical procedures where surgical smoke plume isgenerated. 77% of perioperative practitioners do not have evacuationdevices available in all operating theatres and procedure roomsat their workplaces. Only 14% said plume evacuation equipmentis always used during laparoscopy / endoscopy procedures, wheresurgical smoke plume is readily generated and can be a hazard topatients as well as staff.• Consistent, accurate reporting mechanisms are required to allowstaff to report negative health symptoms. 72% of perioperativepractitioners have experienced symptoms associated with exposureto surgical smoke plume. Only 12% reported these symptoms and, in77% of cases, no follow-up action was taken.Commenting on the findings, Lindsay Keeley, Report Co-author andPatient Safety & Quality Lead at AfPP, said: “This report providesevidence of what we’ve spoken out about for years. Exposure tosurgical smoke plume is one of the most overlooked hazards in theoperating theatre.The Second AnnualOperating Theatres ShowThe Second AnnualTHE KIA OVAL, LONDONOperating 11TH OCTOBER 2022 Theatres ShowTHE KIA OVAL, LONDON11TH Save OCTOBER 20% with 2022code OTJ20www.igpp.org.uk/otjSave 20% with code OTJ20www.igpp.org.uk/otjLindsay Keeley and Penny Smalley, from the Surgical Plume Alliance,launching the survey at the 2021 Future Surgery Show in London“We knew anecdotally that theatre staff continue to be concernedabout this issue, that there was a lack of formalised training andpolicy, and that plume evacuation equipment was often available butin insufficient quantities and used infrequently. These findings providethe first-hand data to support that.“We can now use that data to drive action and change. Alongwith the report, SPA published a position statement on theperioperative management of surgical smoke plume. This outlinesour recommendations to minimise the risks, ensure a safe treatmentenvironment for patients, and provide a safe and healthy workplace forthe perioperative team.”The full report and position statement are available to read here:https://bit.ly/OTJAFPPSP722For anyone who is interested in learning more about the risks ofsurgical smoke plume, and how to manage them, Penny Smalley, ReportCo-author and Director of Education and Regulatory affairs at theInternational Council on Surgical Plume (ICSP), is delivering a session onthe topic at the AfPP Annual Conference 2022. The hybrid Conferencetakes place virtually and at the University of York on 8 – 11 September2022. Tickets are available from afppconf2022.co.uk.When responding to articles please quote ‘OTJ’View the agenda todayView the agenda todayFind out more 02921 680068 • e-mail admin@lawrand.com Issue 382 July 2022 15
Page 1 and 2: THE THETHESEPTEMBER JULY 2020 2022
Page 3 and 4: THE THETHESEPTEMBER JULY 2020 2022
Page 5 and 6: Operating Department Practitioner -
Page 7 and 8: Full Conference: £95One Day: £60w
Page 9 and 10: #StepForwardURGENTLYSEEKING:Consult
Page 11 and 12: Table Five Five - NHS England - NHS
Page 13: Jointoday from£6*AfPP has helped m
Page 17 and 18: Thank you for reading, the extended
Page 19 and 20: The Association for Perioperative P
Page 21 and 22: THESEPTEMBER 2020 ISSUE NO. 360 ISS
Page 23 and 24: www.OperatinggTheatreJobs.comA one-
Page 25 and 26: Becoming an NHS Forest tree sponsor
Page 27 and 28: The Operating Theatre JournalDiscov
Page 29 and 30: Unisurge keeps sight of surgical su
Page 31 and 32: Clinical Update Advantages and Upgr

The Operating Theatre Journal July 2022

Create successful ePaper yourself

Delete template?

Save as template?